#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Eosinophilic oesophagitis Peripheral T-cell lymphoma unspecified Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Mantle cell lymphoma recurrent Pneumonia Antisynthetase syndrome Thromboangiitis obliterans Huntington's disease Thrombocytopenia Liver transplant rejection Arginase deficiency Cardiac failure acute Chronic graft versus host disease in liver Cutaneous calcification Polyneuropathy More trials…

    Learn about Rare Diseases

    Hereditary hypophosphataemic rickets – Trials in Disease Idiopathic inflammatory myopathy – Treatment Ewing’s sarcoma metastatic – Trials in Disease Carcinoid syndrome – Treatment MELAS syndrome – Life with Disease Small intestine leiomyosarcoma – Diagnostics Adrenocortical carcinoma – Life with Disease Pemphigus – Diagnostics Glomerulonephritis membranoproliferative – Diagnostics Biotinidase deficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Carfilzomib Alisertib Sodium Linsitinib Fexofenadine Rondaptivon Pegol Lonvoguran Eptinezumab Salbutamol Sulfate Ph. Eur. Blu-451 Pemetrexed Diacid Monohydrate Resiniferatoxin Fludarabine Lactose Monohydrate Nitrogen Fosamprenavir Calcium Oric-114 F510/08 Vericiguat Sodium Citrate Parsaclisib Hydrochloride More therapies…

    Learn about Your Condition

    Pelizaeus-Merzbacher disease Cancer pain Developmental hip dysplasia Pyoderma gangrenosum Tympanic membrane hyperaemia Ectopic pregnancy Primary hyperaldosteronism Osteoarthritis Meniscus injury Ovarian cancer metastatic Crigler-Najjar syndrome Metastatic neoplasm Embolism venous Alcohol abuse Eye disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on How Methylphenidate Works in Adults with ADHD, Comparing Those with and Without Obesity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    Investigated Drugs:
    • Methylphenidate Hydrochloride
    France

  • Study on Tislelizumab for Elderly Patients with Advanced Esophageal Squamous Cell Carcinoma Unfit for Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal squamous cell carcinoma
    Investigated Drugs:
    • Tislelizumab
    France

  • Study on Anti-CD20 Therapy and Drug Combination for Patients with Relapsing-Remitting Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • Dimethyl Fumarate
    • Diroximel Fumarate
    • Glatiramer Acetate
    France

  • Study on High Dose Dexamethasone for Reducing Post-Surgery Pain in Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    Investigated Drugs:
    • Dexamethasone Disodium Phosphate
    Denmark

  • Study on Preventing Infections in ICU Patients with Interferon Gamma and Sodium Chloride

    Recruiting

    3 1 1
    Investigated Drugs:
    • Recombinant Human Interferon Gamma 1B
    • Sodium Chloride
    France

  • Study of Tarlatamab for Patients with Metastatic or Advanced Small-Cell Lung Cancer and Neuroendocrine Carcinomas

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neuroendocrine carcinoma
    • Small cell lung cancer metastatic
    Investigated Drugs:
    • Tarlatamab
    France Germany
Previous Page
1 … 222 223 224 225 226 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!